Released on: January 8, 2008, 12:56 pm

Press Release Author: Covance, Inc.

Industry: Pharmaceuticals

Press Release Summary: Covance Inc. (NYSE: CVD) plans to relocate its existing
operations in Vienna,Va. to its newly purchased manufacturing facility in the Price
William County Technology Park in Chantilly, Virginia. They have had a facility in
Virginia for over 60 years, and in that time have made significant contributions to
the development of new medicines for HIV/AIDS, breast cancer, diabetes, Alzheimer's,
multiple sclerosis, cystic fibrosis, and many other debilitating diseases.

Press Release Body: Princeton, New Jersey, Jan 08, 2008 - Covance Inc. (NYSE: CVD)
announced today the purchase of a partially constructed manufacturing facility
located on a 47-acre property in Prince William County's Technology Park from Eli
Lilly. The company intends to transform the current facility into a
410,000-square-foot state-of-the-art early drug development laboratory offering
safety testing and chemistry analysis services.

"The increased demand from our biopharmaceutical clients for our preclinical safety
service offerings has led Covance to seek opportunities to enhance and expand our
operations in Northern Virginia and build upon our multi-year global expansion
plans," said Wendel Barr, Covance Senior Vice President and President of Early
Development North America. "For 60 years, Covance operations in Northern Virginia
have made significant contributions to the development of new medicines for
HIV/AIDS, breast cancer, heart disease, leukemia, diabetes, Alzheimer's, multiple
sclerosis, cystic fibrosis, deadly infections, and many other debilitating diseases.
With our long history in the area, we are looking forward to continuing our
relationships as a member of the community as well as contributing to the
diversification of the local economy."

Covance plans to relocate approximately 450 current employees from its existing
operations in Vienna,Va. and Chantilly, Va. to this facility by 2011, and hire an
additional 100 employees by the year 2014. The total planned investment for this
project is approximately $175 million. Covance expects to receive approximately $3.7
million in combined financial incentives from the Commonwealth of Virginia and
Prince William County.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest
and most comprehensive drug development services companies with revenues over the
last twelve months of approximately $1.5 billion, global operations in more than 20
countries, and approximately 8,700 employees worldwide. Information on products and
services, recent press releases, and SEC filings can be obtained through its website
at www.covance.com


Statements contained in this press release, which are not historical facts, such as
statements about prospective earnings, savings, revenue, operations, revenue and
earnings growth and other financial results are forward-looking statements pursuant
to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. All such forward-looking statements including the statements contained herein
regarding anticipated trends in the Company's business are based largely on
management's expectations and are subject to and qualified by risks and
uncertainties that could cause actual results to differ materially from those
expressed or implied by such statements. These risks and uncertainties include,
without limitation, competitive factors, outsourcing trends in the pharmaceutical
industry, levels of industry research and development spending, the Company's
ability to continue to attract and retain qualified personnel, the fixed price
nature of contracts or the loss of large contracts, risks associated with
acquisitions and investments, the Company's ability to increase order volume, the
pace of translation of orders into revenue in late-stage development services, and
other factors described in the Company's filings with the Securities and Exchange
Commission including its Annual Report on Form 10-K and Quarterly Reports on Form
10-Q.

Web Site: http://www.covance.com

Contact Details: Covance, Inc
210 Carnegie Center
Princeton, NJ 08540
Ron Lee netpr@covance.com
http://www.covance.com